Treatment of cornual heterotopic pregnancy via selective reduction without feticide drug
Related Experiment Video
Updated: May 29, 2026
Improved Hysteroscopic Resection of Endometrial Polyps Using 6-Fr Micro-Scissors and Forceps
Published on: August 2, 2024
Zhang Qiong1, Li Yanping, Jagat Prasad Deep
1Centre for Reproductive Medicine, Department of Obstetrics and Gynecology, Xiang-Ya Hospital, Central South University, Changsha, Hunan, China. kindy97@126.com
Study Objective:
To treat heterotopic pregnancy with a minimally invasive procedure, absent a feticide drug.
Design:
Retrospective study (Canadian Classification III).
Setting:
University-affiliated hospital, center of reproductive medicine, department of obstetrics and gynecology, central south university, Changsha Hunan China.
Patients:
A total of nine patients' diagnosed cornual heterotopic pregnancy resulted from assisted reproduction technology. Among nine, five patients selected the cornual embryo reduction.
Interventions:
Cornual embryo reduction and preservation of intrauterine embryo were done under guidance of transvaginal ultrasonography at 4-6 weeks after embryo transfer. No drug was given.
Measurements:
Safety of operative procedure and pregnancy outcome.
Main Results:
All five patients who underwent selective embryo reduction has no intraoperative or postoperative complication, however 3 of them delivered healthy babies while two aborted.
Conclusion:
An early intervention should be carried in vital stable patients by means of puncturing and aspirating cornual heterotopic pregnancy under transvaginal ultrasound guidance.
